BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20802948)

  • 1. Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a brazilian hospital.
    Tuon FF; Bianchet LC; Penteado-Filho SR
    Rev Soc Bras Med Trop; 2010; 43(4):452-4. PubMed ID: 20802948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of extended-spectrum β-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil.
    Nogueira Kda S; Paganini MC; Conte A; Cogo LL; Taborda de Messias Reason I; da Silva MJ; Dalla-Costa LM
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):87-92. PubMed ID: 23587705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency and risk factors for bacteremia caused by extendedspectrum beta-lactamase-producing enterobacteriaceae in patients of a public hospital in Lima, Peru].
    Sarmiento AF; Mejia MN; Rozas AB; Giraldo CA; Málaga G
    Rev Peru Med Exp Salud Publica; 2018; 35(1):62-67. PubMed ID: 29924279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia.
    Menashe G; Borer A; Yagupsky P; Peled N; Gilad J; Fraser D; Riesenberg K; Schlaeffer F
    Scand J Infect Dis; 2001; 33(3):188-93. PubMed ID: 11303808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
    Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
    Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH
    Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
    Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
    J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns.
    Medina-Polo J; Arrébola-Pajares A; Pérez-Cadavid S; Benítez-Sala R; Sopeña-Sutil R; Lara-Isla A; Alsonso-Isa M; Gil-Moradillo J; Justo-Quintas J; Miranda-Utrera N; Aguilar-Gisbert L; Passas-Martínez JB; Tejido-Sánchez Á
    Urol Int; 2015; 95(3):288-92. PubMed ID: 26394031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
    Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
    Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
    Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C;
    Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.
    Ben-Ami R; Schwaber MJ; Navon-Venezia S; Schwartz D; Giladi M; Chmelnitsky I; Leavitt A; Carmeli Y
    Clin Infect Dis; 2006 Apr; 42(7):925-34. PubMed ID: 16511754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
    Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
    Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
    Trecarichi EM; Cauda R; Tumbarello M
    Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan.
    Chen CH; Huang CC
    BMC Infect Dis; 2013 Sep; 13():417. PubMed ID: 24010678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteraemia due to extended-spectrum beta-lactamases (ESBL) and other beta-lactamases (ampC and carbapenemase) producing Enterobacteriaceae: association with health-care and cancer].
    García-Gómez M; Guío L; Hernández JL; Vilar B; Pijoán JI; Montejo JM
    Rev Esp Quimioter; 2015 Oct; 28(5):256-62. PubMed ID: 26437756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.